首页> 外文期刊>Journal of viral hepatitis. >Occult hepatitis B virus infection and its clinical implications.
【24h】

Occult hepatitis B virus infection and its clinical implications.

机译:隐匿性乙型肝炎病毒感染及其临床意义。

获取原文
获取原文并翻译 | 示例
           

摘要

Occult hepatitis B virus (HBV) infection is characterized by presence of HBV infection with undetectable hepatitis B surface antigen (HBsAg). Serum HBV level is usually less than 104 copies/mL in these patients. Diagnosis of occult HBV infection requires sensitive HBV-DNA PCR assay. Several possibilities have been hypothesized as the mechanisms of occult HBV infection. These include: (i) mutations of HBV-DNA sequence; (ii) integration of HBV-DNA into host's chromosomes; (iii) infection of peripheral blood mononuclear cells by HBV; (iv) formation of HBV-containing immune complex; (v) altered host immune response; and (vi) interference of HBV by other viruses. The precise prevalence of occult HBV infection remains to be defined. The clinical implications of occult HBV infection involve different clinical aspects. First of all, occult HBV infection harbours potential risk of HBV transmission through blood transfusion, haemodialysis, and organ transplantation. Second, it may serve as the cause of cryptogenic liver disease, contribute to acute exacerbation of chronic hepatitis B, or even fulminant hepatitis. Third, it is associated with development of hepatocellular carcinoma. Fourth, it may affect disease progression and treatment response of chronic hepatitis C. Most of the previous studies utilized retrospective observation without control groups, and lacked direct association of occult HBV infection with specific pathological changes and disease progression. Highly sensitive, quantitative, and functional molecular analyses of HBV, combined with a well-designed prospective clinical assessment will provide the best approach for the future study of occult HBV infection.
机译:隐匿性乙型肝炎病毒(HBV)感染的特征是存在带有不可检测的乙型肝炎表面抗原(HBsAg)的HBV感染。这些患者的血清HBV水平通常低于104拷贝/ mL。诊断隐性HBV感染需要敏感的HBV-DNA PCR检测。隐匿性HBV感染的机制有几种可能性。这些包括:(i)HBV-DNA序列的突变; (ii)将HBV-DNA整合到宿主的染色体中; (iii)乙肝病毒感染外周血单个核细胞; (iv)形成含HBV的免疫复合物; (v)宿主免疫反应改变; (vi)其他病毒对HBV的干扰。隐匿性HBV感染的确切患病率尚待确定。隐匿性HBV感染的临床意义涉及不同的临床方面。首先,隐匿性HBV感染具有通过输血,血液透析和器官移植传播HBV的潜在风险。其次,它可能是导致隐源性肝病的原因,导致慢性乙型肝炎甚至暴发性肝炎的急性加重。第三,它与肝细胞癌的发展有关。第四,它可能影响慢性丙型肝炎的疾病进展和治疗反应。以前的大多数研究都采用回顾性观察,没有对照组,并且缺乏隐匿性HBV感染与特定病理变化和疾病进展的直接关联。 HBV的高度灵敏,定量和功能性分子分析,再加上精心设计的前瞻性临床评估,将为今后隐匿性HBV感染的研究提供最佳方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号